Consumer Driven Health Care

Patients who have experienced severe stomach complications from the new class of GLP-1 weight loss drugs are now suing Novo Nordisk and Eli Lilly alleging that the drugmakers misled doctors on the drugs' potential risks.

The new state-based initiative, which will launch in 8 states in the fall of 2024, will connect adults with mental health conditions or substance use disorders to a support system by prioritizing collaboration with primary care providers.

Participate in this year's Eastbridge/BenefitsPRO survey to share your input and hear from other brokers on these questions and more. The results will be featured online in May!

An increase in costs amid lower payments from insurance plans makes it harder for small hospitals to fund large capital improvement projects, as hospital closures are reverting to pre-pandemic rates.

With abortion expected to be front and center during election year, Secretary Xavier Becerra has sent a letter to health plans and insurers to "continue to encourage plans and issuers to ensure they are complying with the law."

UnitedHealth, the nation's largest health insurer, attributes Medicare Advantage claims for much of the increased costs, as well as high December COVID-19 hospital admissions, driven by a more infectious variant.

On Feb. 1, the CMS will send its initial offer of a fair price for each of the 10 selected prescription drugs to the drugmakers, who have all filed lawsuits attempting to block the government's effort to control drug prices.

At the 42nd annual event for investors, pharma executives and biotech innovators, the spotlight was on AI, the new GLP-1 class of weight loss drugs, non-profit hospitals and treatment for autoimmune disease.